Skip to search formSkip to main contentSkip to account menu

chlorambucil/dactinomycin/methotrexate protocol

Known as: MAC, Chlorambucil/Dactinomycin/Methotrexate, CLB/DACT/MTX 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (4)

Antineoplastic Combined Chemotherapy ProtocolsChlorambucilDactinomycinMethotrexate

Narrower (1)

Methotrexate-Actinomycin-Chlorambucil Regimen
cyclophosphamide/dactinomycin/methotrexate protocolcyclophosphamide/doxorubicin/mitomycin protocol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Myeloid Angiogenic Cells Act as Alternative M2 Macrophages and Modulate Angiogenesis through Interleukin-8
Endothelial progenitor cells (EPCs) promote angiogenesis, and clinical trials have shown such cell therapy to be feasible for… 
Highly Cited
2010
Highly Cited
2010
Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for…
This retrospective study assessed the outcome of 576 adult acute lymphoblastic leukemia patients aged ≥ 45 years, and who… 
Highly Cited
2009
Highly Cited
2009
Energy-Efficient Low Duty Cycle MAC Protocol for Wireless Body Area Networks
This paper presents an energy-efficient medium access control protocol suitable for communication in a wireless body area network… 
Highly Cited
2007
Highly Cited
2007
Reducing climate change impacts on agriculture: Global and regional effects of mitigation, 2000–2080
Highly Cited
2005
Highly Cited
2005
Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
BACKGROUND The long-term outcome and spectrum of disease of nontuberculous mycobacterial immune reconstitution syndrome have not… 
Highly Cited
2001
Highly Cited
2001
Dendritic cells as a major source of macrophage‐derived chemokine/CCL22 in vitro and in vivo
Macrophage‐derived chemokine (MDC)/CCL22 is a CC chemokine active on dendritic cells (DC), NK cells and Th2 lymphocytes. The… 
Highly Cited
2001
Highly Cited
2001
Are Estimates of MAC Reliable?
Background Potency of inhaled anesthetics (minimum alveolar concentration [MAC]) is typically studied in humans using an “up–down… 
Highly Cited
1995
Highly Cited
1995
Clinical Characteristics of Sevoflurane in Children: A Comparison with Halothane
Background For pediatric patients, sevoflurane may be an alternative to halothane, the anesthetic agent used most commonly for… 
Review
1980
Review
1980
Determination and applications of MAC.
Highly Cited
1975
Highly Cited
1975
MAC Expanded: AD50 and AD95 Values of Common Inhalation Anesthetics in Man
Two important measures may be derived from patient responses to a range of anesthetic doses. The AD50, corresponding to MAC… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)